STELFONTA Progress with European Medicines Authority

November 2019

The European Medicines Authority, Committee for Medicinal Products for Veterinary Use (CVMP) adopted by majority a positive opinion for an initial marketing authorisation application for STELFONTA®, from QBiotics Group Limited. This supports STELFONTA® (tigilanol tiglate) as an oncology veterinary product. Formal registration confirmation is expected early January.